| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Outset Medical (NASDAQ:OM) reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Outset Medical beat estimated earnings by 3.28%, reporting an EPS of $-0.59 versus an estimate of $-0.61.
Revenue was down $1.50 million from the same period last year.
Last quarter the company missed on EPS by $0.03 which was followed by a 14.39% drop in the share price the next day.
Here's a look at Outset Medical's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.68 | -0.73 | -0.74 | -0.86 |
| EPS Actual | -0.71 | -0.69 | -0.72 | -0.71 |
| Revenue Estimate | 30.39M | 35.18M | 31.76M | 30.92M |
| Revenue Actual | 30.36M | 36.04M | 33.47M | 32.01M |
To track all earnings releases for Outset Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: OM
